Berman Capital Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$5K Buy
176
+40
+29% +$1.29K ﹤0.01% 1417
2021
Q2
$4K Buy
136
+1
+0.7% +$33 ﹤0.01% 1387
2021
Q1
$3K Sell
135
-2
-1% -$53 ﹤0.01% 1400
2020
Q4
$3K Buy
137
+2
+1% +$48 ﹤0.01% 1275
2020
Q3
$2K Buy
135
+1
+0.7% +$19 ﹤0.01% 1263
2020
Q2
$2K Sell
134
-437
-77% -$5.53K ﹤0.01% 1247
2020
Q1
$4K Buy
571
+179
+46% +$2.58K ﹤0.01% 928
2019
Q4
$7K Buy
392
+306
+356% +$5.08K ﹤0.01% 866
2019
Q3
$1K Sell
86
-101
-54% -$1.64K ﹤0.01% 1293
2019
Q2
$4K Sell
187
-105
-36% -$3.09K ﹤0.01% 1005
2019
Q1
$10K Buy
292
+31
+12% +$1.13K ﹤0.01% 649
2018
Q4
$7K Buy
+261
New +$8.26K ﹤0.01% 591

Other funds holding CC

Berman Capital Advisors's CC Position: Q3 2021 in Review

Berman Capital Advisors increased its Chemours (CC) stake by 29% in Q3 2021, buying an estimated $1.29K and bringing the position to 176 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Berman Capital Advisors first reported a position in CC in Q4 2018 and has held it in 12 quarters since. The position peaked at $10K in Q1 2019. 460 funds tracked by Wall St. Rank hold CC as of Q3 2021.

  • Berman Capital Advisors held 176 shares of Chemours worth $5K as of Q3 2021.
  • Berman Capital Advisors bought 40 Chemours shares in Q3 2021, an estimated $1.29K.
  • Chemours made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1417 holding.
  • Berman Capital Advisors first reported a position in Chemours in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Chemours position peaked at $10K in Q1 2019.
  • 460 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.